Towards regulatory cellular therapies in solid organ transplantation
Organ transplantation is a modern medical success story. However, since its inception it has been limited by the need for pharmacological immunosuppression. Regulatory cellular therapies offer an attractive solution to these challenges by controlling transplant alloresponses through multiple paralle...
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Journal article |
| Dil: | English |
| Baskı/Yayın Bilgisi: |
Cell Press
2021
|
| _version_ | 1826313404566994944 |
|---|---|
| author | Bottomley, MJ Brook, MO Shankar, S Hester, J Issa, F |
| author_facet | Bottomley, MJ Brook, MO Shankar, S Hester, J Issa, F |
| author_sort | Bottomley, MJ |
| collection | OXFORD |
| description | Organ transplantation is a modern medical success story. However, since its inception it has been limited by the need for pharmacological immunosuppression. Regulatory cellular therapies offer an attractive solution to these challenges by controlling transplant alloresponses through multiple parallel suppressive mechanisms. A number of cell types have seen an accelerated development into human trials and are now on the threshold of a long-awaited breakthrough in personalized transplant therapeutics. Here we assess recent developments with a focus on the most likely candidates, some of which have already facilitated successful immunosuppression withdrawal in early clinical trials. We propose that this may constitute a promising approach in clinical transplantation but also evaluate outstanding issues in the field, providing cause for cautious optimism. |
| first_indexed | 2024-09-25T04:12:35Z |
| format | Journal article |
| id | oxford-uuid:aac1f979-8104-44b8-99c0-ca1fc104a784 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-09-25T04:12:35Z |
| publishDate | 2021 |
| publisher | Cell Press |
| record_format | dspace |
| spelling | oxford-uuid:aac1f979-8104-44b8-99c0-ca1fc104a7842024-06-27T13:41:44ZTowards regulatory cellular therapies in solid organ transplantationJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:aac1f979-8104-44b8-99c0-ca1fc104a784EnglishSymplectic ElementsCell Press2021Bottomley, MJBrook, MOShankar, SHester, JIssa, FOrgan transplantation is a modern medical success story. However, since its inception it has been limited by the need for pharmacological immunosuppression. Regulatory cellular therapies offer an attractive solution to these challenges by controlling transplant alloresponses through multiple parallel suppressive mechanisms. A number of cell types have seen an accelerated development into human trials and are now on the threshold of a long-awaited breakthrough in personalized transplant therapeutics. Here we assess recent developments with a focus on the most likely candidates, some of which have already facilitated successful immunosuppression withdrawal in early clinical trials. We propose that this may constitute a promising approach in clinical transplantation but also evaluate outstanding issues in the field, providing cause for cautious optimism. |
| spellingShingle | Bottomley, MJ Brook, MO Shankar, S Hester, J Issa, F Towards regulatory cellular therapies in solid organ transplantation |
| title | Towards regulatory cellular therapies in solid organ transplantation |
| title_full | Towards regulatory cellular therapies in solid organ transplantation |
| title_fullStr | Towards regulatory cellular therapies in solid organ transplantation |
| title_full_unstemmed | Towards regulatory cellular therapies in solid organ transplantation |
| title_short | Towards regulatory cellular therapies in solid organ transplantation |
| title_sort | towards regulatory cellular therapies in solid organ transplantation |
| work_keys_str_mv | AT bottomleymj towardsregulatorycellulartherapiesinsolidorgantransplantation AT brookmo towardsregulatorycellulartherapiesinsolidorgantransplantation AT shankars towardsregulatorycellulartherapiesinsolidorgantransplantation AT hesterj towardsregulatorycellulartherapiesinsolidorgantransplantation AT issaf towardsregulatorycellulartherapiesinsolidorgantransplantation |